Open Government Canada
Notice - Prescription Drug List (PDL): Levonorgestrel
Published by Health Canada | Santé Canada
About this dataset
The purpose of this Notice of Amendment is to notify that Health Canada has revised the listing for levonorgestrel on the Prescription Drug List (PDL). Only the Human part of the PDL was revised; the listing for Veterinary use will remain unchanged.